###begin article-title 0
Comprehensive molecular etiology analysis of nonsyndromic hearing impairment from typical areas in China
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Every year, 30,000 babies are born with congenital hearing impairment in China. The molecular etiology of hearing impairment in the Chinese population has not been investigated thoroughly. To provide appropriate genetic testing and counseling to families, we performed a comprehensive investigation of the molecular etiology of nonsyndromic deafness in two typical areas from northern and southern China.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3</italic>
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6</italic>
###xml 284 291 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4</italic>
###xml 293 301 293 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">12S rRNA</italic>
###xml 303 311 303 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and tRNA</italic>
###xml 311 314 311 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ser</italic>
###xml 315 318 315 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UCN</italic>
###xml 311 320 311 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ser</italic>(<italic>UCN</italic>) </sup>
###xml 364 372 364 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 32 40 <span type="species:ncbi:9606">children</span>
###xml 350 358 <span type="species:ncbi:9606">patients</span>
A total of 284 unrelated school children with hearing loss who attended special education schools in China were enrolled in this study, 134 from Chifeng City in Inner Mongolia and the remaining 150 from Nangtong City in JiangSu Province. Screening was performed for GJB2, GJB3, GJB6, SLC26A4, 12S rRNA, and tRNAser(UCN) genes in this population. All patients with SLC26A4 mutations or variants were subjected to high-resolution temporal bone CT scan to verify the enlarged vestibular aqueduct.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 159 167 159 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 304 312 304 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 388 393 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 397 405 397 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
###xml 217 225 <span type="species:ncbi:9606">patients</span>
Mutations in the GJB2 gene accounted for 18.31% of the patients with nonsyndromic hearing loss, 1555A>G mutation in mitochondrial DNA accounted for 1.76%, and SLC26A4 mutations accounted for 13.73%. Almost 50% of the patients with nonsyndromic hearing loss in these typical Chinese areas carried GJB2 or SLC26A4 mutations. No significant differences in mutation spectrum or prevalence of GJB2 and SLC26A4 were found between the two areas.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 187 195 187 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 227 233 227 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA </italic>
###xml 284 294 284 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3, GJB6</italic>
###xml 300 310 300 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA tRNA</italic>
###xml 310 313 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ser</italic>
###xml 314 317 314 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UCN</italic>
###xml 310 319 310 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ser</italic>(<italic>UCN</italic>) </sup>
###xml 402 406 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 408 415 408 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4</italic>
###xml 435 444 435 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">12S rRNA </italic>
###xml 159 167 <span type="species:ncbi:9606">patients</span>
In this Chinese population, 54.93% of cases with hearing loss were related to genetic factors. The GJB2 gene accounted for the etiology in about 18.31% of the patients with hearing loss, SLC26A4 accounted for about 13.73%, and mtDNA 1555A>G mutation accounted for 1.76%. Mutations in GJB3, GJB6, and mtDNA tRNAser(UCN) were not common in this Chinese cohort. Conventionally, screening is performed for GJB2, SLC26A4, and mitochondrial 12S rRNA in the Chinese deaf population.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 414 419 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 429 437 429 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 63 69 <span type="species:ncbi:9606">humans</span>
###xml 118 126 <span type="species:ncbi:9606">children</span>
###xml 573 581 <span type="species:ncbi:9606">children</span>
###xml 820 826 <span type="species:ncbi:9606">people</span>
###xml 867 875 <span type="species:ncbi:9606">children</span>
Hearing impairment is the most common neurosensory disorder in humans, with an incidence of approximately one in 1000 children worldwide. About 50-60% of these cases have a genetic cause [1]. In China, it has been estimated that 30,000 babies are born with congenital hearing impairment per 20 million live births every year [2]. Although some mutational hotspots involved in inherited hearing impairment, such as GJB2 235 delC, SLC26A4 IVS7-2A>G, and mitochondrial DNA 1555A>G, have been reported in Chinese deaf populations, the molecular etiology of deafness in Chinese children has not been investigated systematically, and effective genetic evaluation strategies for hearing impairment are not available in most areas of China. China is a large country with a population of 1.3 billion, of which 91% are Han ethnic people. Comprehensive genetic analysis of deaf children in different regions of China should be performed to obtain epidemiological information to provide effective genetic testing and accurate counseling.
###end p 11
###begin p 12
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 457 462 457 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 519 524 519 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 537 542 537 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 645 650 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 909 914 909 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 918 923 918 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 924 925 924 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 926 928 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 987 992 987 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 1025 1030 1025 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1065 1067 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1068 1070 1068 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 305 313 <span type="species:ncbi:9606">patients</span>
###xml 376 384 <span type="species:ncbi:9606">patients</span>
###xml 768 776 <span type="species:ncbi:9606">patients</span>
The most common molecular defects in nonsyndromic autosomal recessive deafness involve Connexin 26, a gap junction protein encoded by the GJB2 gene [3-10]. More than 150 mutations, polymorphisms, and unclassified variants of GJB2 have been reported to account for the molecular etiology of about 8-40% of patients with nonsyndromic hearing impairment . However, almost 79% of patients with nonsyndromic hereditary deafness in China do not have mutations in GJB2 [11]. Indeed, mutations in other connexin genes, such as GJB6 for Cx30 and GJB3 for Cx31, have been identified and shown to cause hearing impairment [12,13]. Sequence analysis of the GJB2 gene in subjects with autosomal recessive hearing impairment has revealed a puzzling problem in that a high number of patients carry only one mutant allele. Some of these families showed clear evidence of linkage to the DFNB1 locus, which contains two genes, GJB2 and GJB6 [3,14]. Further analysis demonstrated a deletion truncating the GJB6 gene, encoding connexin 30, near GJB2 in heterozygous affected subjects [15,16].
###end p 12
###begin p 13
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 159 167 159 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 380 388 380 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 389 390 389 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 420 428 420 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
SLC26A4 also makes appreciable contributions to autosomal recessive nonsyndromic deafness, enlargement of the vestibular aqueduct (EVA), and Pendred syndrome. SLC26A4 encodes an anion (chloride/iodide) transporter transmembrane protein, pendrin, which is expressed in the thyroid, kidney, and cochlea [17,18]. DNA sequence analysis identified more than 100 different mutations in SLC26A4 [8,19-25]. It was reported that SLC26A4 mutations accounted for approximately 5% of all cases of prelingual deafness in East Asia, 5% of cases of recessive deafness in south Asia [26], 3.5% in the UK, and 4% in the Caucasian population with nonsyndromic hearing loss [27].
###end p 13
###begin p 14
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA</italic>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 291 300 291 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">12S rRNA </italic>
###xml 364 373 364 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">12S rRNA </italic>
###xml 428 437 428 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">12S rRNA </italic>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 501 510 501 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">12S rRNA </italic>
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 798 802 798 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tRNA</italic>
###xml 802 805 802 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ser</italic>
###xml 806 809 806 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UCN</italic>
###xml 802 811 802 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ser</italic>(<italic>UCN</italic>) </sup>
###xml 934 936 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 937 939 937 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 946 952 946 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA </italic>
###xml 1121 1123 1121 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1124 1126 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1252 1254 1252 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1255 1257 1255 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1002 1010 <span type="species:ncbi:9606">patients</span>
Although the majority of cases with hereditary hearing loss are caused by nuclear gene defects, it has become clear that mutations in mitochondrial DNA (mtDNA) can also cause nonsyndromic hearing loss [28,29]. The best studied of these mutations is the 1555A>G mutation in the mitochondrial 12S rRNA gene. Another recently identified mutation in the mitochondrial 12S rRNA gene is the 1494C>T in the conserved stem structure of 12S rRNA [30]. Other nucleotide changes at positions 961 and 1095 in the 12S rRNA gene have been shown to be associated with hearing loss, but their pathogenic mechanisms of action in the predisposition of carriers to aminoglycoside toxicity are much less clear [31,32]. Several mutations (7444G>A, 7445A>G, 7472insC, 7510T>C, 7511T>C, and 7512T>C) in the mitochondrial tRNAser(UCN) gene are also known to cause maternally inherited nonsyndromic hearing loss by disrupting the tRNA structure and function [33-35]. The mtDNA 1555A>G mutation accounts for a small fraction of patients with nonsyndromic hearing loss, with frequencies between 0.6% and 2.5% among different Caucasian populations [36-40] and higher frequencies in Asian countries (3.43%, 3%, and 5.3% in Chinese, Japanese, and Indonesian cohorts, respectively) [41-43].
###end p 14
###begin p 15
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3</italic>
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6</italic>
###xml 117 124 117 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4</italic>
###xml 126 140 126 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA 12S rRNA</italic>
###xml 142 156 142 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and mtDNA tRNA</italic>
###xml 156 159 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ser</italic>
###xml 160 163 160 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UCN</italic>
###xml 156 164 156 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ser</italic>(<italic>UCN</italic>)</sup>
###xml 173 181 <span type="species:ncbi:9606">patients</span>
###xml 479 487 <span type="species:ncbi:9606">patients</span>
In the present study, we performed a comprehensive analysis of 6 prominent deafness-related genes, GJB2, GJB3, GJB6, SLC26A4, mtDNA 12S rRNA, and mtDNA tRNAser(UCN), in 284 patients with early-onset, nonsyndromic hearing impairment from unrelated families from two typical Chinese areas, Chifeng City in northern China and Nantong City in southern China, to investigate the molecular etiology in order to provide effective risk assessment and genetic counseling for hearing loss patients and their families in China.
###end p 15
###begin title 16
Materials and methods
###end title 16
###begin title 17
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and DNA samples
###end title 17
###begin p 18
###xml 1046 1054 <span type="species:ncbi:9606">patients</span>
###xml 1178 1186 <span type="species:ncbi:9606">patients</span>
###xml 1225 1228 <span type="species:ncbi:9606">Man</span>
###xml 1545 1552 <span type="species:ncbi:9606">patient</span>
A total of 284 deaf subjects from unrelated families were included in this study; 134 were from Chifeng Special Education School in Inner Mongolia, and 150 were from Nantong Special Education School in JiangSu Province, China. The Huanghe River is the demarcation line between northern and southern China. Chifeng is a typical city in northern China with a population of 4.61 million, and Nantong is a typical city in southern China with a population of 7.74 million. Chifeng and Nantong are moderate on the population scales in northern and southern China, respectively. Chifeng and Nantong both have long histories of 8000 years and at least 5000 years, respectively. No significant population immigration has occurred over the history of the two cities, and the genetic backgrounds of the respective populations remain relatively intact. The two cities have relatively stable economic development, and the living habits and cultural background of the populations are characteristic of northern and southern China, respectively. This cohort of patients consisted of 158 males and 126 females from 3 to 20 years old with an average age of 12.30 +/- 2.70 years. Ethnically, the patients consisted of 243 Han, 31 Mongolian, 7 Man, and 3 Hui Chinese. The study protocol was performed with the approval of the ethnicity committee of the Chinese PLA General Hospital. Informed consent was obtained from all subjects prior to blood sampling. Parents were interviewed with regard to age of onset, family history, mother's health during pregnancy, and patient's clinical history, including infection, possible head or brain injury, and the use of aminoglycoside antibiotics.
###end p 18
###begin p 19
###xml 251 259 <span type="species:ncbi:9606">patients</span>
All subjects showed moderate to profound bilateral sensorineural hearing impairment on audiograms. Careful medical examinations revealed no clinical features other than hearing impairment. DNA was extracted from the peripheral blood leukocytes of 284 patients with nonsyndromic hearing loss and 200 region- and race-matched controls with normal hearing using a commercially available DNA extraction kit (Watson Biotechnologies Inc, Shanghai, China).
###end p 19
###begin title 20
Mutational analysis
###end title 20
###begin p 21
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 119 128 119 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">12S rRNA </italic>
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tRNA</italic>
###xml 155 158 155 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ser</italic>
###xml 159 162 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UCN</italic>
###xml 155 164 155 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ser</italic>(<italic>UCN</italic>) </sup>
###xml 508 513 508 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 560 565 560 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 626 630 626 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 632 637 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 680 685 680 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 739 744 739 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 765 767 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 943 948 943 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 279 287 <span type="species:ncbi:9606">patients</span>
###xml 482 490 <span type="species:ncbi:9606">Patients</span>
###xml 850 858 <span type="species:ncbi:9606">Children</span>
DNA sequence analysis of the GJB2 coding region plus approximately 50 bp of the flanking intron regions, mitochondrial 12S rRNA (nt611 to nt2007), and tRNAser(UCN) (nt7148 to nt8095) genes were amplified by PCR followed by sequencing using the Big Dye sequencing protocol in all patients. The sequence results were analyzed using an ABI 3100 DNA sequencing machine (Applied Biosystems, Foster City, CA) and ABI 3100 Analysis Software v.3.7 NT, according to manufacturer's protocol. Patients with monoallelic GJB2 coding region mutation were further tested for GJB2 IVS1+1G>A mutation or defects in exon1 and basal promoter of GJB2, GJB6 309-kb deletion, and deletion of the whole GJB6 coding region. The presence of the 309-kb deletion of GJB6 was analyzed by PCR [15,16]. A positive control (provided by Balin Wu, Department of Laboratory Medicine, Children's Hospital Boston and Harvard Medical School, Boston, MA) was used for detection of GJB6 gene deletions.
###end p 21
###begin p 22
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA </italic>
###xml 115 123 115 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 147 155 147 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 176 184 <span type="species:ncbi:9606">patients</span>
Patients with two GJB2 mutant alleles, one dominant mutant allele, or mtDNA 1555A>G mutation were not analyzed for SLC26A4 mutations. The exons of SLC26A4 of the remaining 227 patients were sequenced individually starting from the frequently mutated exons until two mutant alleles were identified.
###end p 22
###begin p 23
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA </italic>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 204 212 <span type="species:ncbi:9606">patients</span>
Patients with two GJB2 mutant alleles, one dominant mutant allele, mtDNA 1555A>G mutation, or verified EVA were not analyzed for GJB3 mutations. The coding exon of GJB3 was sequenced in the remaining 188 patients.
###end p 23
###begin p 24
###xml 120 130 120 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2, GJB3</italic>
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 151 166 151 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA 12S rRNA </italic>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tRNA</italic>
###xml 174 177 174 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ser</italic>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UCN</italic>
###xml 174 182 174 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ser</italic>(<italic>UCN</italic>)</sup>
###xml 228 236 228 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
Two hundred controls with normal hearing were sequenced to determine the presence of mutations and polymorphisms in the GJB2, GJB3, and GJB6 genes and mtDNA 12S rRNA and tRNAser(UCN). In addition, all controls were screened for SLC26A4 mutations by DHPLC followed by sequencing analysis.
###end p 24
###begin title 25
CT scan and thyroid examination
###end title 25
###begin p 26
###xml 55 63 55 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 326 334 326 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 16 24 <span type="species:ncbi:9606">patients</span>
###xml 304 312 <span type="species:ncbi:9606">patients</span>
Fifty-six of 59 patients with mutations or variants in SLC26A4 were examined by temporal bone computed tomography (CT) scan for diagnosis of EVA or inner ear malformation based on a diameter of >1.5 mm at the midpoint between the common crus and the external aperture [28]. To evaluate Pendred syndrome, patients positive for SLC26A4 mutations or variants were examined by ultrasound scan of the thyroid and determination of thyroid hormone levels. These procedures were performed at the Second Hospital of Chifeng City, Inner Mongolia and hospitals affiliated with Nantong University, China. As perchlorate discharge testing is not a general clinical practice in China, it was not used in this study.
###end p 26
###begin title 27
Results
###end title 27
###begin p 28
###xml 578 580 572 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 455 463 <span type="species:ncbi:9606">patients</span>
Among the 284 cases included in this study, 139 cases had prelingual hearing loss, including 94 congenital cases. Fifty-six cases showed postlingual hearing loss, with an average age of onset of 3.01 +/- 1.86 years. The age of onset was unclear in the remaining 89 cases. In addition, 79 cases (22 prelingual cases and 57 postlingual cases) had clear histories of administration of aminoglycoside, with an average age of onset at 2.23 +/- 1.71 years, and patients without a history of aminoglycoside use showed a significantly lower average age of onset of 0.75 +/- 1.07 years (P < 0.001).
###end p 28
###begin title 29
GJB2 gene mutations
###end title 29
###begin p 30
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 523 524 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 682 683 682 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 808 812 808 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 959 964 959 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
###xml 112 119 <span type="species:ncbi:9606">patient</span>
###xml 272 280 <span type="species:ncbi:9606">patients</span>
###xml 298 305 <span type="species:ncbi:9606">patient</span>
###xml 402 410 <span type="species:ncbi:9606">patients</span>
###xml 542 550 <span type="species:ncbi:9606">patients</span>
###xml 748 756 <span type="species:ncbi:9606">patients</span>
Sequence analysis of the GJB2 gene indicated that 51 patients carried two confirmed pathogenic mutations, and 1 patient had an R75W mutation, which has been reported to cause autosomal dominant syndromic deafness with palmoplantar keratoderma [44] (Table 1). Twenty-eight patients, including the 1 patient with autosomal dominant R75W mutation, were heterozygous for one pathogenic mutant allele. Four patients were heterozygous for one unclassified novel variant, the pathogenicity of which has not been determined (Table 1). In addition, 3 patients carried the heterozygous allele V37I, about which there is debate regarding whether it is a pathogenic mutation or a polymorphism [8,45-47]. Thus, 29.23% (83/284) of the unrelated families of deaf patients in typical areas in China had molecular defects in GJB2, and 18.31% (52/284) had confirmed molecular etiology of nonsyndromic hearing impairment (51 autosomal recessive and 1 autosomal dominant) in the GJB2 gene.
###end p 30
###begin p 31
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 13 21 <span type="species:ncbi:9606">patients</span>
Genotypes of patients with mutations in the GJB2 gene
###end p 31
###begin p 32
TM, transmembrane domain; EC, extracellular domain; IC, intracellular domain.
###end p 32
###begin p 33
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 334 335 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 516 517 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 695 696 695 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 995 1000 995 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1062 1064 1062 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1102 1104 1102 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1202 1203 1202 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1204 1206 1204 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1207 1209 1207 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1210 1212 1210 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1213 1215 1213 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1387 1388 1387 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1389 1391 1389 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1392 1394 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1640 1642 1640 1642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1643 1645 1643 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 215 222 <span type="species:ncbi:9606">patient</span>
###xml 352 360 <span type="species:ncbi:9606">patients</span>
###xml 837 845 <span type="species:ncbi:9606">patients</span>
###xml 1017 1025 <span type="species:ncbi:9606">patients</span>
###xml 1346 1353 <span type="species:ncbi:9606">patient</span>
###xml 1717 1724 <span type="species:ncbi:9606">patient</span>
Five frameshift (235delC, 299_300delAT, 176_191del16, 560_605ins46, and 155_158delTCTG) and two missense (T86R and R75W) pathogenic mutations were found in this cohort (Table 1). The most prevalent mutation in this patient cohort was 235delC, which has also been reported to be the most prevalent mutation in other Asian populations [6,46]. Thirty-one patients were homozygous for 235delC mutation, 14 were compound heterozygous with another pathogenic mutation, and 20 were heterozygous for 235delC mutation (Table 1). Four novel alterations were identified, specifically, a frameshift pathogenic 155_158delTCTG mutation and three unclassified missense variants, V198M, V63L, and V153A (Tables 1). Overall, 134 mutant alleles (including the unclassified missense variants but excluding the V37I variant) were identified in 83 unrelated patients. 235delC alone accounted for 71.64% (96/134) of the total mutant alleles. Two mutations, 235delC and 299delAT, accounted for 85.07% (114/134) of the GJB2 mutations in our patients, 91% in another Chinese population [47], and 97% in a Taiwanese population [48]. These detection rates were higher among all the studies on the Asian deaf populations to date [6,10,45,46,48]. The V37I variant was considered a pathogenic mutation in Japanese studies, but it was not found in any of the Korean control or patient populations reported previously [6,10,46]. The frequency of V37I in our deaf population was lower than that in our control group (P < 0.05). T123N is an unclassified variant, which was counted as a mutation in a previous Japanese study but as a polymorphism in another study in Taiwan [10,45]. We found three T123N alleles in our control subjects but none in the patient group.
###end p 33
###begin p 34
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 603 608 603 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 649 654 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 715 717 713 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 727 729 725 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 102 110 <span type="species:ncbi:9606">patients</span>
###xml 255 262 <span type="species:ncbi:9606">patient</span>
###xml 317 320 <span type="species:ncbi:9606">Man</span>
###xml 321 328 <span type="species:ncbi:9606">patient</span>
###xml 388 395 <span type="species:ncbi:9606">patient</span>
###xml 435 438 <span type="species:ncbi:9606">Man</span>
###xml 439 446 <span type="species:ncbi:9606">patient</span>
###xml 458 461 <span type="species:ncbi:9606">Man</span>
###xml 462 470 <span type="species:ncbi:9606">patients</span>
###xml 494 502 <span type="species:ncbi:9606">patients</span>
No variations in the GJB2 gene mutation spectra were found among the different ethnicities of Chinese patients in our study, with 235delC being the most common mutation in all ethnic groups. The 299_300delAT mutation was found in 15 Han, 1 Mon, and 1 Hui patient. The deleterious 560_605ins46 mutation was found in 1 Man patient. The 176_191del16 mutation was detected in 8 Han and 1 Mon patient, and 155_158 delTCTG was detected in 1 Man patient. Four of 7 Man patients (57%) and about 30% of patients from all other races [27.98% (68/243) of Han, 32.3% (10/31) of Mon, and 33.3% (1/3) of Hui] carried GJB2 mutations. No significant differences in GJB2 detection rate were found among these four ethnic groups (chi2 = 2.4893, P = 0.4772).
###end p 34
###begin p 35
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 334 339 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 501 502 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
We analyzed the GJB2 gene from 200 control subjects with normal hearing and found three types of deleterious mutation, 235delC, 299_300delAT, and 139G>T(E47X), carried by 7 subjects in the heterozygous state. This suggested a GJB2 mutation carrier rate of about 3.5% (7/200) in the general population. Meanwhile, the carrier rates of GJB2 mutation in Korea, Japan, Taiwan, among Ashkenazi Jews, and in the Midwestern United States were reported to be 2%, 2.08%, 2.55%, 4.76%, and 3.01%, respectively [5,6,45,46,49].
###end p 35
###begin p 36
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 12 20 <span type="species:ncbi:9606">patients</span>
None of our patients heterozygous for one GJB2 mutant allele or the controls with normal hearing carried the IVS1+1G>A mutation or variant in exon1 and basal promoter of GJB2.
###end p 36
###begin title 37
Mutations in GJB6
###end title 37
###begin p 38
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 12 20 <span type="species:ncbi:9606">patients</span>
None of our patients heterozygous for one GJB2 mutant allele or the controls with normal hearing had the known 309-kb deletion or other variant in the GJB6 gene.
###end p 38
###begin title 39
###xml 36 44 36 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ser(UCN)</sup>
Mutations in mtDNA 12S rRNA and tRNAser(UCN)
###end title 39
###begin p 40
###xml 107 122 107 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA 12S rRNA </italic>
###xml 192 202 192 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA tRNA</italic>
###xml 202 205 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ser</italic>
###xml 206 209 206 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UCN</italic>
###xml 202 211 202 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ser</italic>(<italic>UCN</italic>) </sup>
###xml 375 384 375 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">12S rRNA </italic>
###xml 387 391 387 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tRNA</italic>
###xml 391 394 391 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ser</italic>
###xml 395 398 395 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UCN</italic>
###xml 391 400 391 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ser</italic>(<italic>UCN</italic>) </sup>
###xml 501 509 501 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 652 660 652 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 754 769 754 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA 12S rRNA </italic>
###xml 5 13 <span type="species:ncbi:9606">patients</span>
###xml 62 70 <span type="species:ncbi:9606">patients</span>
###xml 132 140 <span type="species:ncbi:9606">patients</span>
###xml 237 245 <span type="species:ncbi:9606">patients</span>
###xml 314 322 <span type="species:ncbi:9606">patients</span>
###xml 442 450 <span type="species:ncbi:9606">patients</span>
###xml 597 604 <span type="species:ncbi:9606">patient</span>
###xml 931 938 <span type="species:ncbi:9606">patient</span>
Five patients were found to carry the 1555A>G mutation, and 4 patients carried the 1095T>C mutation in the mtDNA 12S rRNA gene. Two patients were detected carrying the 7444G>A mutation in the mtDNA tRNAser(UCN) gene. All of the above 11 patients had a clear history of aminoglycoside use. None of the remaining 68 patients with history of aminoglycoside use had mutations in 12S rRNA or tRNAser(UCN) in the mitochondrial genome. One of the 2 patients with 7444G>A mutation was also homozygous for the SLC26A4 IVS7-2A>G mutation and was further verified to have EVA by temporal CT scan. Thus, this patient may be only a 7444G>A carrier, with defects in SLC26A4 being the main cause of hearing loss. Two of the 200 control subjects were found to carry the mtDNA 12S rRNA 1095T>C mutation, giving a carrier rate of 1% (2/200). Statistical analysis showed no significant difference in the incidence of the 1095T>C mutation between the patient and control groups. No other mutations were detected in the mitochondrial genome in the controls. All the mutations found in the mitochondrial genome were homogeneous.
###end p 40
###begin title 41
Mutations in SLC26A4
###end title 41
###begin p 42
###xml 25 33 25 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 301 309 301 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 592 597 592 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1289 1297 1289 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
###xml 98 106 <span type="species:ncbi:9606">patients</span>
###xml 280 288 <span type="species:ncbi:9606">patients</span>
###xml 330 338 <span type="species:ncbi:9606">patients</span>
###xml 510 518 <span type="species:ncbi:9606">patients</span>
###xml 650 658 <span type="species:ncbi:9606">patients</span>
###xml 747 755 <span type="species:ncbi:9606">patients</span>
###xml 898 906 <span type="species:ncbi:9606">patients</span>
###xml 997 1004 <span type="species:ncbi:9606">patient</span>
###xml 1335 1343 <span type="species:ncbi:9606">patients</span>
Sequence analysis of the SLC26A4 gene in these 227 patients with hearing impairment identified 28 patients with two confirmed pathogenic mutations (Table 2) and one compound heterozygote for two unclassified variants, Y375C and R470H, which are most likely pathogenic. Twenty-one patients carried one SLC26A4 mutant allele, and 2 patients carried novel unclassified missense variants, I491T and L597S, respectively, which are probably pathogenic due to the changes in evolutionarily conserved amino acids. Two patients carried V659L, including 1 who was verified to have EVA by CT scan. Wang et al. reported the pathogenicity of V659L in Chinese EVA patients [25]. Two unclassified heterozygous missense variants were found, I235V and T67S. The 2 patients carrying these single conserved amino acid changes had normal vestibular aqueducts. These two missense variants are probably benign, or these patients were only carriers of the mutation and their hearing impairment had other etiologies. One patient with normal results on temporal CT scan carried a novel variant, IVS12-6insT, in the heterozygous state. Analysis using the program NNSPLICE available at  did not predict gain or loss of a splice site with this variant, and it was therefore also considered benign. Thus, mutations in SLC26A4 were identified in 18.66% (53/284) of patients with hearing impairment in typical areas of China, 29 with two mutant alleles and 24 with one mutant allele.
###end p 42
###begin p 43
###xml 13 21 13 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
Genotypes of SLC26A4 gene-related hearing impairment in typical Chinese areas
###end p 43
###begin p 44
nl, normal; EVA, enlarged vestibular aqueduct; ND, not determined; NA, not available; IVS7, intravening sequence 7 (intron 7); IVS12, intravening sequence 12 (intron 12).
###end p 44
###begin p 45
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 668 676 <span type="species:ncbi:9606">patients</span>
###xml 996 1004 <span type="species:ncbi:9606">patients</span>
A total of seven different pathogenic mutations (IVS7-2A>G, E37X, K77I, S391R, N392Y, T410M, H723R) and five novel, probably pathogenic variants (Y375C, R470H, I491T, L597S, and H723D) were found. The E37X mutation that results in a premature stop codon and a truncated protein less than 5% of the normal length is predicted to be deleterious. The H723D mutation is caused by nucleotide substitution, c.2167C>G, which was predicted to be deleterious as a milder change at the same amino acid residue, H723R, was shown to be the most common pathogenic mutation in Japanese subjects. Other missense mutations, K77I, S391R, N392Y, T410M, and H723R, have been reported in patients with hearing loss [24,25,50]. Y375C, R470H, I491T, L597S, and H723D were considered pathogenic, as they are located in an evolutionarily conserved region. The substituted amino acids are structurally and functionally different from those in the wild-type sequence, and Y375C, R470H, I491T, and H723D have been found in patients with EVA or other forms of inner ear malformation and were not found in our normal controls.
###end p 45
###begin p 46
###xml 328 336 328 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 377 378 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 32 39 <span type="species:ncbi:9606">patient</span>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
The most common mutation in our patient cohort was the aberrant splice-site alteration, IVS7-2A>G, for which 16 patients were homozygous, 4 were compound heterozygous, and 17 were heterozygous. The IVS7-2A>G mutation accounted for 64.63% (53/82, counting only the definite pathogenic and most likely pathogenic variants) of all SLC26A4 mutant alleles in this population (Table 2).
###end p 46
###begin p 47
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Three novel silent variants were identified in the patients, c.1905C>G (E635E), c.678T>C (A226A), and c.225C>G (L75L), which were not detected in the control group.
###end p 47
###begin p 48
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 250 258 250 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 327 335 327 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 414 419 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
To determine the carrier frequency in the general population, SLC26A4 exons 2-21 of 200 individuals with normal hearing were analyzed by DHPLC. Four IVS7-2A>G heterozygotes and one silent variant, 2217A>G (Q739Q), were found. The carrier rate of the SLC26A4 mutation in China was estimated to be about 2%. Polymorphisms in the SLC26A4 gene appear to be rare in the general population in comparison to those in the GJB2 gene.
###end p 48
###begin title 49
CT scan
###end title 49
###begin p 50
###xml 747 748 747 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 72 80 <span type="species:ncbi:9606">patients</span>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
###xml 263 270 <span type="species:ncbi:9606">patient</span>
###xml 404 411 <span type="species:ncbi:9606">patient</span>
###xml 507 515 <span type="species:ncbi:9606">patients</span>
###xml 562 569 <span type="species:ncbi:9606">patient</span>
###xml 631 639 <span type="species:ncbi:9606">patients</span>
###xml 805 813 <span type="species:ncbi:9606">patients</span>
###xml 901 909 <span type="species:ncbi:9606">patients</span>
Temporal CT scan revealed EVA and/or other inner ear malformation in 39 patients. Twenty-eight patients had EVA and two pathogenic mutant alleles, consistent with an autosomal recessive disorder caused by biallelic loss of function of pendrin protein. One female patient carrying two novel missense variants, Y375C and R470H, had a common cystic cavity of the cochlea and vestibule without EVA. One male patient carrying a novel I491T variant had enlarged vestibular aqueducts with Mondini dysplasia. Eight patients with one mutant IVS7-2A>G allele had EVA. One patient with one mutant 2168A>G allele had EVA. CT scan results of 3 patients carrying heterozygous IVS7-2A>G, N392Y, and a polymorphism (L75L), respectively, were not available (Table 2). Temporal CT scan results were normal in the remaining patients. Testing of the two most frequent mutations, IVS7-2A>G and H723R, identified 89.74% of patients with EVA or inner ear malformation in this cohort.
###end p 50
###begin title 51
Thyroid ultrasound and thyroid hormone assays
###end title 51
###begin p 52
###xml 107 115 107 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 93 101 <span type="species:ncbi:9606">patients</span>
###xml 175 182 <span type="species:ncbi:9606">patient</span>
###xml 381 389 <span type="species:ncbi:9606">patients</span>
Thyroid ultrasound was performed to determine the presence or absence of goiter. None of the patients with SLC26A4 mutations or variants showed the presence of goiter. Only 1 patient with EVA showed cystoid changes in the thyroid on ultrasound scan, whereas no changes were observed in thyroid hormone levels. Thyroid hormone assays showed that total T3 was slightly elevated in 2 patients, but this was of no clinical significance, according to endocrinologists from Chinese PLA General Hospital.
###end p 52
###begin title 53
Mutations in GJB3
###end title 53
###begin p 54
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 559 564 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 783 788 783 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1135 1140 1135 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
###xml 254 262 <span type="species:ncbi:9606">patients</span>
###xml 608 615 <span type="species:ncbi:9606">patient</span>
###xml 729 736 <span type="species:ncbi:9606">patient</span>
###xml 1002 1010 <span type="species:ncbi:9606">patients</span>
###xml 1121 1129 <span type="species:ncbi:9606">patients</span>
Sequence analysis of the GJB3 gene identified five heterozygous variants in 44 patients: 24_49ins26bp (GCCATGGACTGGAAGACACTCCAGGC), 87C>T (F29F), 250A>G (V84I), 357C>T (N119N), and 497A>G (N166S) (Table 3). Both 87C>T and 357C>T are silent variants. Two patients were heterozygous for 250A>G (V84I). To clarify the pathogenicity of the V84I variant, we performed a control study in a group of 200 individuals with normal hearing. The frequency of V84I in the deaf population was not significantly different from that in the controls, but it was shown to be a GJB3 polymorphism in the Chinese population. One patient was heterozygous for 497A>G, which results in replacement of asparagine with serine at position 166 of Cx31. The patient carrying N166S mutation in one allele carried GJB2 235delC mutation in the other allele. The 24_49ins26bp variant is a novel frameshift, which results in a premature stop codon and a truncated Cx31 protein. In addition, 24_49ins26bp and N166S were detected only in patients with hearing impairment and not in the controls, and they are very likely to be deleterious mutations. Only 2 patients with GJB3 mutation were found in this cohort.
###end p 54
###begin p 55
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 13 21 <span type="species:ncbi:9606">patients</span>
Genotypes of patients and controls with variants in GJB3 gene
###end p 55
###begin p 56
TM, transmembrane domain; EC, extracellular domain; IC, intracellular domain.
###end p 56
###begin p 57
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 390 398 <span type="species:ncbi:9606">patients</span>
###xml 598 606 <span type="species:ncbi:9606">patients</span>
Five types of GJB3 variant were detected in the control group: 357C>T (N119N), 87C>T (F29F), 327C>T (H109H), 250A>G (V84I), and 580G>A (A194T). One control subject was homozygous for 250A>G (V84I). 327C>T is a silent variant. The variant 580G>A was predicted to replace the hydrophobic alanine at position 194 of Cx31 with a hydrophilic threonine (A194T). This variant was first found in 2 patients from China with autosomal dominant hearing loss and was considered to be a genetic cause in these two cases [51]. We regard A194T as an unclassified variant because it was not detected in any of our patients. Long-term follow-up is necessary in the 2 controls with A194T mutation to determine whether their hearing level will show any impairment in future.
###end p 57
###begin title 58
Discussion
###end title 58
###begin title 59
GJB2 gene
###end title 59
###begin p 60
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 712 717 712 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 172 180 <span type="species:ncbi:9606">patients</span>
###xml 541 544 <span type="species:ncbi:9606">Man</span>
Previous reports suggested that the prevalence of GJB2 mutations varies among different ethnic groups. The most common mutation in Caucasians, 35delG, was not found in our patients. Instead, 235delC accounted for 71.64% of GJB2 mutant alleles in our cohort. This is mutation is detected at the highest rates among Asian populations, with incidences of approximately 41% and 57% in two Japanese reports, 67% in one Taiwanese study, and 73% in one Korean study [6,10,45,46,48]. The Chinese population is made up of six major ethnicities: Han, Man, Mon, Hui, Zhuang, and Miao. The majority are Han (91.6%), and this was also the predominant ethnicity in the study population (85.56%). No significant differences in GJB2 mutation spectra were found among different ethnicities in the Chinese population, although the numbers in the non-Han populations were too small to allow final conclusions to be reached in our study.
###end p 60
###begin p 61
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 700 708 700 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1500 1502 1500 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1503 1505 1503 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 42 49 <span type="species:ncbi:9606">patient</span>
###xml 219 227 <span type="species:ncbi:9606">patients</span>
###xml 265 272 <span type="species:ncbi:9606">patient</span>
###xml 999 1006 <span type="species:ncbi:9606">patient</span>
###xml 1084 1091 <span type="species:ncbi:8355">Xenopus</span>
###xml 1093 1098 <span type="species:ncbi:10090">mouse</span>
###xml 1100 1103 <span type="species:ncbi:10116">rat</span>
###xml 1105 1110 <span type="species:ncbi:9940">sheep</span>
###xml 1112 1121 <span type="species:ncbi:9600|species:ncbi:9601">orangutan</span>
###xml 1127 1132 <span type="species:ncbi:9606">human</span>
###xml 1183 1191 <span type="species:ncbi:9606">patients</span>
###xml 1529 1537 <span type="species:ncbi:9606">patients</span>
The missense mutation T86R was found in 1 patient who was also compound heterozygous for 235delC mutation. Although this mutation is not listed in the GJB2 mutation database website , it had been reported in 3 Japanese patients [10]. The 15-year-old Chinese female patient with R75W mutation developed thickening and peeling of the skin at medial and lateral sides of both hands and feet at 1 year of age. Pure-tone audiometry testing showed that her father had moderate high-frequency hearing loss, whereas her mother had normal hearing. Her father and mother did not have similar skin problems. GJB2 sequencing indicated that neither of her parents carried the R75W mutation. Therefore, R75W was a de novo mutation in this subject. This mutation has been reported previously in association with autosomal dominant deafness and palmoplantar keratoderma [44]. Three missense variants, V63L, V153A, and V198M, likely contribute to the pathogenesis of deafness, because they were detected only in the patient group and not in the control group, and they are evolutionarily conserved in Xenopus, mouse, rat, sheep, orangutan, and human. These mutations were heterozygous in 4 unrelated patients who carried only one mutant allele. It is not clear if they represent autosomal dominant mutations or are autosomal recessive with an as-yet unidentified second mutant allele in either the same gene (deep in introns or untranslated regions) or in different genes (digenic synergistic heterozygous mutations)[16,52]. Alternatively, these patients may simply be coincidental carriers whose deafness is caused by non-genetic environmental factors.
###end p 61
###begin p 62
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 416 421 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 496 501 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 758 763 758 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 780 785 780 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 832 837 832 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 872 876 872 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 965 970 965 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 971 973 971 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 989 994 989 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1047 1053 1047 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA </italic>
###xml 1111 1113 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 1133 1138 1133 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
###xml 1215 1220 1215 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 28 36 <span type="species:ncbi:9606">patients</span>
###xml 86 93 <span type="species:ncbi:9606">patient</span>
###xml 161 169 <span type="species:ncbi:9606">patients</span>
###xml 402 410 <span type="species:ncbi:9606">patients</span>
###xml 890 898 <span type="species:ncbi:9606">patients</span>
###xml 1252 1260 <span type="species:ncbi:9606">patients</span>
In our study population, 51 patients had two confirmed pathogenic mutations, plus the patient carrying the dominant R75W, and deafness in 18.31% (52/284) of our patients was due to mutations in GJB2. The percentage of GJB2-related hearing loss in other studies was 5.9-7% in Taiwan, 4.8% in Korea, 10.3% in the US, 13.5% in Australia, and 14.3% in Germany [6,8,9,45,48,53]. A significant proportion of patients with GJB2 mutations had only one mutant allele. Carriers of a single mutation in the GJB2 gene show evidence of reduced hair cell function [54]. Thus, it is possible that these carriers are more likely than are non-carriers to develop hearing impairment in the presence of other genetic defects or environmental factors. In addition to the common GJB6 309-kb deletion, GJB2 IVS1+1G>A is another mutant DFNB1 allele. Toth et al. reported that 23.4% of Hungarian GJB2-heterozygous patients carried the splice-site mutation IVS1+1G>A in the 5'UTR region of GJB2 [55]. In addition, GJB2 mutations may act synergistically in the presence of mtDNA 1555A>G mutation with aminoglycoside-induced ototoxicity [56]. Deletions in the GJB6 gene, the IVS1+1G>A mutation, or variants in exon1 and the basal promoter of GJB2 were not detected in any of the patients in the present study.
###end p 62
###begin title 63
SLC26A4 gene
###end title 63
###begin p 64
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 207 214 207 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4</italic>
###xml 220 228 220 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
###xml 344 352 <span type="species:ncbi:9606">patients</span>
###xml 655 663 <span type="species:ncbi:9606">patients</span>
###xml 824 832 <span type="species:ncbi:9606">patients</span>
SLC26A4 gene mutations were detected in nearly 20% of our nonsyndromic hearing impairment patients, with IVS7-2A>G being the most prevalent mutation. About 14% (39/284) of our cases were due to mutations in SLC26A4. The SLC26A4 gene is another common gene involved in deafness in typical areas in China. To identify Pendred syndrome in the EVA patients, we performed thyroid hormone testing and ultrasound scan of the thyroid to examine the function and structure of the thyroid instead of perchlorate discharge testing, a routine method used for examining thyroid function that is not available in most areas of China. Our results indicated that none of patients had Pendred syndrome. The discrepancy between our results and those of previous studies may be explained by differences in testing methods used; the age of the patients, as those undergoing thyroid ultrasound and thyroid hormone assays in this study (3 to 20, average 12.3 +/- 2.7) may have been too young to show symptoms; and/or phenotypic diversity due to differences in genetic background.
###end p 64
###begin p 65
###xml 474 482 474 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 503 506 503 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e</italic>
###xml 38 46 <span type="species:ncbi:9606">patients</span>
It is interesting to note that the 10 patients with inner ear malformation carried one missense mutation only. Whether the missense mutation causes a dominant negative effect and/or specifies a different phenotype is not clear. It is possible that the second mutant allele has not yet been identified due to the location of mutations deep in introns or promoter regions that were not sequenced, intragenic exon deletions, or the involvement of mutations in genes other than SLC26A4 in the pathogenesis (i.e., digenic synergistic mutations).
###end p 65
###begin p 66
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 506 511 506 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 674 682 674 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 735 743 735 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 530 538 <span type="species:ncbi:9606">patients</span>
###xml 657 665 <span type="species:ncbi:9606">patients</span>
###xml 782 790 <span type="species:ncbi:9606">patients</span>
The SLC26A4 mutation spectrum in typical areas in China is similar to that reported in the overall Chinese population but different from that in Japan. Research findings indicate a gradient shift of the most prevalent mutation from IVS7-2A>G to H723R from Chinese to Japanese, respectively, with both mutations being equally prevalent in the Korean population. This observation suggests that IVS7-2A>G and H723R mutations may be ancient mutations in China and Japan, respectively. A recent study by Albert et al. of 100 unrelated patients with EVA in European Caucasian subjects revealed a diverse mutation spectrum without prevalent mutations, and only 40 patients carried SLC26A4 mutations [24]. It is not clear why the mutations in SLC26A4 account for a much lower percentage of patients with EVA in Caucasian populations. Presumably, other genetic factors and environmental factors are involved in the pathogenesis of EVA in Caucasian populations.
###end p 66
###begin p 67
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 78 86 78 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
We found no significant differences in the spectrum or prevalence of GJB2 and SLC26A4 between patients from Chifeng City and those from Nantong City.
###end p 67
###begin title 68
###xml 29 37 29 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ser(UCN)</sup>
mtDNA 12S rRNA and mtDNA tRNAser(UCN)
###end title 68
###begin p 69
###xml 323 329 323 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA </italic>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 6 14 <span type="species:ncbi:9606">patients</span>
###xml 159 167 <span type="species:ncbi:9606">patients</span>
All 5 patients with 1555A>G mutation in the present study had a history of aminoglycoside use. Pedigree analysis showed maternally inherited traits, and these patients were diagnosed as having aminoglycoside-induced nonsyndromic hearing loss. We investigated the clinical and molecular characteristics of three of the four mtDNA 1095T>C pedigrees. The extremely low penetrance of hearing loss in the Chinese families carrying the 1095T>C mutation strongly suggested that the 1095T>C mutation itself is not sufficient to produce the clinical phenotype. Therefore, other modifiers, including aminoglycosides, nuclear genes, and mitochondrial haplotypes, are necessary for the phenotypic manifestation of the 1095T>C mutation. Despite the presence of several highly evolutionarily conserved variants in protein-coding genes and the 16S rRNA gene [57], the extremely low penetrance of hearing loss with the 1095T>C mutation implies that the mitochondrial variants may not have a modifying role in phenotypic expression of the 1095T>C mutation in these Chinese families. However, the history of exposure to aminoglycosides in these 3 hearing-impaired subjects suggested that these agents were probably the cause of hearing loss. Two controls were also found to carry the 1095T>C mutation; they were advised to avoid use of aminoglycosides, and their hearing level is being followed closely.
###end p 69
###begin p 70
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 237 243 237 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA </italic>
###xml 224 231 <span type="species:ncbi:9606">patient</span>
###xml 527 534 <span type="species:ncbi:9606">patient</span>
###xml 651 658 <span type="species:ncbi:9606">patient</span>
The 7444G>A substitution has been described in deaf individuals with and without the 1555A>G mutation, but its pathogenicity has not been established [58]. Yao et al. considered 7444G>A to be a normal polymorphism [59]. The patient with mtDNA 7444G>A mutation, who began suffering bilateral hearing impairment within 3 months after administration of streptomycin, had no relevant family history. We performed PCR amplification of fragments spanning the entire mitochondrial genome, and subsequent DNA sequence analysis in this patient revealed no variants in evolutionarily conserved regions in the mitochondrial genome. The molecular etiology of the patient carrying 7444G>A mutation remains to be identified.
###end p 70
###begin title 71
GJB3 gene
###end title 71
###begin p 72
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 16 18 16 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3</italic>
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 198 203 198 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 326 331 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 608 613 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1111 1120 1111 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1208 1213 1208 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 1217 1222 1217 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1248 1250 1248 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 1286 1291 1286 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1295 1300 1295 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 1489 1494 1489 1494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 1965 1973 1965 1973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 540 547 <span type="species:ncbi:9606">patient</span>
###xml 894 899 <span type="species:ncbi:10090">mouse</span>
###xml 1007 1012 <span type="species:ncbi:9606">human</span>
###xml 1330 1337 <span type="species:ncbi:9606">patient</span>
###xml 1472 1479 <span type="species:ncbi:9606">patient</span>
###xml 1793 1800 <span type="species:ncbi:9606">patient</span>
###xml 1941 1948 <span type="species:ncbi:9606">patient</span>
Richard et al. [60] identified three mutations in the Connexin31 gene (GJB3) in four families with erythrokeratodermia variabilis (EKV). Independently, Xia et al. [13] reported cloning of the human GJB3 gene on chromosome 1p33-p35 and found mutations in two small families with deafness. The observation that some carriers of GJB3 mutations showed a normal phenotype challenges the involvement of these mutations in dominant deafness. GJB3 has been shown to be related to early-onset autosomal recessive deafness. In the present study, the patient carrying N166S mutation in one allele was verified to carry GJB2 235delC mutation in the other. Direct physical interaction of Cx26 with Cx31 is supported by data showing that Cx26 and Cx31 have overlapping expression patterns in the cochlea. In addition, we identified the presence of heteromeric Cx26/Cx31 connexons by coimmunoprecipitation of mouse cochlear membrane proteins. Furthermore, by cotransfection of mCherry-tagged Cx26 and GFP-tagged Cx31 into human embryonic kidney (HEK)-293 cells, we demonstrated that the two connexins were able to co-assemble in vitro in the same junction plaque. The above data indicate that a genetic interaction between GJB3 and GJB2 can lead to hearing loss [61]. A diagnosis of digenic inherited GJB2 and GJB3 hearing loss was made in this patient. The frameshift mutation 24_49ins26bp (GCCATGGACTGGAAGACACTCCAGGC) generates a putative truncated protein of only 18 amino acids. The patient carrying GJB3 24_49ins26bp in our cohort had congenital symmetric hearing loss with no relevant family history. The severity of her hearing impairment was profound. Unfortunately, blood samples from her parents were not available for analysis. If one of the parents with normal hearing carries this mutation, the patient may only be a carrier. Alternatively, if neither of the parents with normal hearing carries this mutation, the 24_49ins26bp mutation in the patient may have arisen de novo and may be the genetic cause or at least one of the factors responsible for her phenotype.
###end p 72
###begin p 73
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 135 143 135 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 230 235 230 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 239 246 239 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4</italic>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 327 333 327 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MtDNA </italic>
###xml 500 541 500 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2, GJB3, GJB6, SLC26A4, mtDNA 12S rRNA</italic>
###xml 546 556 546 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA tRNA</italic>
###xml 556 559 556 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ser</italic>
###xml 560 563 560 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UCN</italic>
###xml 556 565 556 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ser</italic>(<italic>UCN</italic>) </sup>
###xml 748 762 748 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA 12SrRNA </italic>
###xml 785 790 785 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3 </italic>
###xml 54 62 <span type="species:ncbi:9606">patients</span>
###xml 190 198 <span type="species:ncbi:9606">patients</span>
###xml 289 296 <span type="species:ncbi:9606">patient</span>
###xml 401 409 <span type="species:ncbi:9606">patients</span>
###xml 433 441 <span type="species:ncbi:9606">patients</span>
###xml 617 625 <span type="species:ncbi:9606">patients</span>
###xml 723 731 <span type="species:ncbi:9606">patients</span>
###xml 768 775 <span type="species:ncbi:9606">patient</span>
###xml 868 876 <span type="species:ncbi:9606">patients</span>
Taken together, approximately 47.89% (83 + 53/284) of patients with NSHI in typical Chinese areas had molecular defects in the GJB2 or SLC26A4 gene, whereas about 33.1% and 3.5% of European patients with NSHI carried mutations in GJB2 and SLC26A4, respectively, with a total of 36.6% in a patient cohort of 142 sib pairs [30]. MtDNA 1555A>G mutation accounted for the etiology in 1.76% (5/284) of the patients with hearing loss. Ten patients with a family history of hearing loss showed mutations in GJB2, GJB3, GJB6, SLC26A4, mtDNA 12S rRNA, or mtDNA tRNAser(UCN) in our study population. The etiologies of these 10 patients are most likely genetic, although no mutations in common hearing loss genes were found. If the 4 patients with 1095T>C in mtDNA 12SrRNA and 1 patient carrying GJB3 24_49ins26 were all included, hearing loss in 54.93% (156/284) of our Chinese patients was related to genetic factors.
###end p 73
###begin p 74
###xml 118 123 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 127 135 127 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 290 298 290 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
This is the first comprehensive study of the molecular etiology of nonsyndromic hearing impairment in mainland China. GJB2 and SLC26A4 are the two most common etiologies for deafness in the Chinese population. A preliminary investigation of the mutation spectrum and prevalence of GJB2 and SLC26A4 between typical areas from northern and southern China was performed in this study, and no significant differences were found.
###end p 74
###begin title 75
Conclusion
###end title 75
###begin p 76
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 284 291 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4</italic>
###xml 297 303 297 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA </italic>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB3</italic>
###xml 341 345 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6</italic>
###xml 351 361 351 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA tRNA</italic>
###xml 361 364 361 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ser</italic>
###xml 365 368 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UCN</italic>
###xml 361 370 361 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ser</italic>(<italic>UCN</italic>) </sup>
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 406 413 406 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4</italic>
###xml 419 428 419 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">12S rRNA </italic>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
###xml 206 214 <span type="species:ncbi:9606">patients</span>
###xml 499 507 <span type="species:ncbi:9606">patients</span>
###xml 564 572 <span type="species:ncbi:9606">patients</span>
In this study, a total of 54.93% of Chinese patients with hearing impairment showed evidence of genetic involvement either based on genetic screening or family history, and 18.31%, 13.73%, and 1.76% of the patients were determined to have inherited hearing impairment caused by GJB2, SLC26A4, and mtDNA 1555A>G mutations. Mutations in GJB3, GJB6, and mtDNA tRNAser(UCN) are not common. Screening for GJB2, SLC26A4, and 12S rRNA should be considered the first step in genetic testing of deaf Chinese patients. Furthermore, the molecular defects of about 66% of the patients with nonsyndromic hearing impairment in China remain to be identified.
###end p 76
###begin title 77
Competing interests
###end title 77
###begin p 78
The authors declare that they have no competing interests.
###end p 78
###begin title 79
Authors' contributions
###end title 79
###begin p 80
YoYu, YiYo, and DH carried out the molecular genetic studies and participated in sequence alignment. YoYu drafted the manuscript. YW and QW carried out temporal CT scan and thyroid hormone assays. JC, FY, and DK participated in sequence alignment and performed the statistical analyses. HY and DH participated in the design of the study. PD conceived the study, participated in its design and coordination, and helped draft the manuscript. All authors have read and approved the final manuscript.
###end p 80
###begin title 81
Acknowledgements
###end title 81
###begin p 82
This work was supported by Chinese National Nature Science Foundation Research Grant (30572015, 30728030, 30872862), Beijing Nature Science Foundation Research Grant (7062062) to Dr. Pu Dai, and Chinese National Nature Science Foundation Research Grant (30801285) to Dr. Yongyi Yuan.
###end p 82
###begin article-title 83
Epidemiology, etiology and genetic patterns
###end article-title 83
###begin article-title 84
###xml 22 30 <span type="species:ncbi:9606">patients</span>
Molecular etiology of patients with nonsyndromic hearing loss from deaf-mute schools in 18 provinces of China
###end article-title 84
###begin article-title 85
Connexin-26 mutations in sporadic and inherited sensorineural deafness
###end article-title 85
###begin article-title 86
Connexin-26 mutations in sporadic non-syndromal sensorineural deafness
###end article-title 86
###begin article-title 87
Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness
###end article-title 87
###begin article-title 88
Connexin26 mutations associated with nonsyndromic hearing loss
###end article-title 88
###begin article-title 89
Molecular basis of childhood deafness resulting from mutations in the GJB2 (connexin 26) gene
###end article-title 89
###begin article-title 90
High frequency hearing loss correlated with mutations in the GJB2 gene
###end article-title 90
###begin article-title 91
Mutations in the connexin26/GJB2 gene are the most common event in nonsyndromic hearing loss among the German population
###end article-title 91
###begin article-title 92
GJB2 deafness gene shows a specific spectrum of mutations in Japan, including a frequent founder mutation
###end article-title 92
###begin article-title 93
###xml 65 73 <span type="species:ncbi:9606">patients</span>
Mutation of GJB2 gene in Chinese nonsyndromic hearing impairment patients: analysis of 1190 cases
###end article-title 93
###begin article-title 94
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB6 </italic>
Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus
###end article-title 94
###begin article-title 95
Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment
###end article-title 95
###begin article-title 96
Identification of mutations in the connexin 26 gene that cause autosomal recessive nonsyndromic hearing loss
###end article-title 96
###begin article-title 97
A novel deletion involving the connexin-30 gene, del(GJB6-d13s1854), found in trans with mutations in the GJB2 gene (connexin-26) in subjects with DFNB1 non-syndromic hearing impairment
###end article-title 97
###begin article-title 98
A deletion involving the connexin 30 gene in nonsyndromic hearing impairment
###end article-title 98
###begin article-title 99
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
Expression pattern of the mouse ortholog of the Pendred's syndrome gene (Pds) suggests a key role for pendrin in the inner ear
###end article-title 99
###begin article-title 100
Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells
###end article-title 100
###begin article-title 101
SLC26A4/PDS genotype-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and nonsyndromic EVA are distinct clinical and genetic entities
###end article-title 101
###begin article-title 102
Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations
###end article-title 102
###begin article-title 103
Screening of SLC26A4 (PDS) gene in Pendred's syndrome: a large spectrum of mutations in France and phenotypic heterogeneity
###end article-title 103
###begin article-title 104
Genetic basis of hearing loss associated with enlarged vestibular aqueducts in Koreans
###end article-title 104
###begin article-title 105
Pendred syndrome and DFNB4-mutation screening of SLC26A4 by denaturing high-performance liquid chromatography and the identification of eleven novel mutations
###end article-title 105
###begin article-title 106
SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations
###end article-title 106
###begin article-title 107
###xml 44 52 <span type="species:ncbi:9606">patients</span>
A distinct spectrum of SLC26A4 mutations in patients with enlarged vestibular aqueduct in China
###end article-title 107
###begin article-title 108
Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness
###end article-title 108
###begin article-title 109
Assessment of the genetic causes of recessive childhood nonsyndromic deafness in the UK - implications for genetic testing
###end article-title 109
###begin article-title 110
Mitochondrial genetics and hearing loss: the missing link between genotype and phenotype
###end article-title 110
###begin article-title 111
Mitochondrial defects and hearing loss
###end article-title 111
###begin article-title 112
Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family
###end article-title 112
###begin article-title 113
Heteroplasmy for the 1555A>G mutation in the mitochondrial 12S rRNA gene in six Spanish families with non-syndromic hearing loss
###end article-title 113
###begin article-title 114
Cosegregation of C-insertion at position 961 with the A1555G mutation of the mitochondrial 12S rRNA gene in a large Chinese family with maternally inherited hearing loss
###end article-title 114
###begin article-title 115
###xml 39 45 <span type="species:ncbi:9606">humans</span>
Hereditary deafness and phenotyping in humans
###end article-title 115
###begin article-title 116
Mitochondrial defects and hearing loss
###end article-title 116
###begin article-title 117
The deafness-associated mitochondrial DNA mutation at position which affects tRNASer(UCN) precursor processing, has long-range effects on NADH dehydrogenase subunit ND6 gene expression
###end article-title 117
###begin article-title 118
###xml 105 113 <span type="species:ncbi:9606">patients</span>
Mutation A1555G in the 12S rRNA gene and its epidemiological importance in German, Hungarian, and Polish patients
###end article-title 118
###begin article-title 119
###xml 53 61 <span type="species:ncbi:9606">patients</span>
The A1555G mtDNA mutation in Danish hearing-impaired patients: frequency and clinical signs
###end article-title 119
###begin article-title 120
###xml 53 61 <span type="species:ncbi:9606">children</span>
###xml 90 96 <span type="species:ncbi:9103">Turkey</span>
Frequency of mtDNA A1555G and A7445G mutations among children with prelingual deafness in Turkey
###end article-title 120
###begin article-title 121
Molecular analysis of the mitochondrial 12S rRNA and tRNASer(UCN) genes in paediatric subjects with nonsyndromic hearing loss
###end article-title 121
###begin article-title 122
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Mitochondrial DNA mutations in patients with postlingual, nonsyndromic hearing impairment
###end article-title 122
###begin article-title 123
Large-scale screening of mtDNA A1555G mutation in China and its significance in prevention of aminoglycoside antibiotic induced deafness
###end article-title 123
###begin article-title 124
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Prevalence of mitochondrial gene mutations among hearing impaired patients
###end article-title 124
###begin article-title 125
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Prevalence of the mitochondrial DNA A1555G mutation in sensorineural deafness patients in island Southeast Asia
###end article-title 125
###begin article-title 126
Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma
###end article-title 126
###begin article-title 127
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Mutation spectrum of the connexin 26 (GJB2) gene in Taiwanese patients with prelingual deafness
###end article-title 127
###begin article-title 128
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
Prevalent connexin 26 gene (GJB2) mutations in Japanese
###end article-title 128
###begin article-title 129
GJB2 gene mutations in newborns with non-syndromic hearing impairment in Northern China
###end article-title 129
###begin article-title 130
Mutations of Cx26 gene (GJB2) for prelingual deafness in Taiwan
###end article-title 130
###begin article-title 131
Carrier Rate of the Midwestern United States For GJB2 Mutations Causing Inherited Deafness
###end article-title 131
###begin article-title 132
Distribution and frequencies of PDS (SLC26A4) mutations in Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct: a unique spectrum of mutations in Japanese
###end article-title 132
###begin article-title 133
Study of the relation between Cx31 gene and hereditary hearing impairment
###end article-title 133
###begin article-title 134
Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways
###end article-title 134
###begin article-title 135
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
DNA sequence analysis of GJB2, encoding connexin 26: Observations from a population of hearing impaired cases and variable carrier rates, complex genotypes and ethnic stratification of alleles among controls
###end article-title 135
###begin article-title 136
The effects of a connexin 26 mutation--35delG--on oto-acoustic emissions and brainstem evoked potentials: homozygotes and carriers
###end article-title 136
###begin article-title 137
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Coincidence of mutations in different connexin genes in Hungarian patients
###end article-title 137
###begin article-title 138
Connexin 26 gene (GJB2) mutation modulates the severity of hearing loss associated with the 1555A-->G mitochondrial mutation
###end article-title 138
###begin article-title 139
Extremely low penetrance of deafness associated with the mitochondrial 12S rRNA 1095T>C mutation in three Chinese families
###end article-title 139
###begin article-title 140
The role and frequency of mitochondrial mutations in two distinct populations: The USA and Mongolia
###end article-title 140
###begin article-title 141
A reappraisal of complete mtDNA variation in East Asian families with hearing impairment
###end article-title 141
###begin article-title 142
###xml 17 22 <span type="species:ncbi:9606">human</span>
Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis
###end article-title 142
###begin article-title 143
Digenic inheritance of non-syndromic deafness caused by mutations at the gap junction proteins Cx26 and Cx31
###end article-title 143

